Therapeutic options for extended-spectrum β-lactamases (ESBLs), AmpC β-lactamases producing Escherichia coli and Klebsiella sp. isolated from various clinical samples

Vimal Kumar; Narinder Kaur; Shubham Chauhan; Rosy Bala; Jyoti Chauhan; Harit Kumar; Shivani Devi

About The Authors

Vimal Kumar
Department of Microbiology, Maharishi Markandeshwar Institute of Medical Science and Research, Maharishi Markandeshwar (Deemed to be) University, Mullana, Ambala, India
India

Narinder Kaur
* Corresponding Author
Department of Microbiology, Maharishi Markandeshwar Institute of Medical Science and Research, Maharishi Markandeshwar (Deemed to be) University, Mullana, Ambala, India
India

Shubham Chauhan
Department of Microbiology, Maharishi Markandeshwar Institute of Medical Science and Research, Maharishi Markandeshwar (Deemed to be) University, Mullana, Ambala, India
India

Rosy Bala
Department of Microbiology, Maharishi Markandeshwar Institute of Medical Science and Research, Maharishi Markandeshwar (Deemed to be) University, Mullana, Ambala, India
India

Jyoti Chauhan
Department of Microbiology, Maharishi Markandeshwar Institute of Medical Science and Research, Maharishi Markandeshwar (Deemed to be) University, Mullana, Ambala, India
India

Harit Kumar
Department of Microbiology, Maharishi Markandeshwar Institute of Medical Science and Research, Maharishi Markandeshwar (Deemed to be) University, Mullana, Ambala, India
India

Shivani Devi
Department of Microbiology, Maharishi Markandeshwar Institute of Medical Science and Research, Maharishi Markandeshwar (Deemed to be) University, Mullana, Ambala, India